Herbert F. Oettgen

18.2k total citations · 4 hit papers
221 papers, 14.6k citations indexed

About

Herbert F. Oettgen is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Herbert F. Oettgen has authored 221 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Immunology, 78 papers in Molecular Biology and 71 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Herbert F. Oettgen's work include Monoclonal and Polyclonal Antibodies Research (66 papers), Immunotherapy and Immune Responses (50 papers) and Glycosylation and Glycoproteins Research (39 papers). Herbert F. Oettgen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (66 papers), Immunotherapy and Immune Responses (50 papers) and Glycosylation and Glycoproteins Research (39 papers). Herbert F. Oettgen collaborates with scholars based in United States, Germany and Japan. Herbert F. Oettgen's co-authors include Lloyd J. Old, Kenneth O. Lloyd, Carl Pinsky, Hiroshi Shiku, L J Old, Willet F. Whitmore, Susan E. Krown, Harold J. Wanebo, Francisco X. Real and Wolfgang Dippold and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Herbert F. Oettgen

217 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium

1988 763 citations Janice Gabrilove, Ann A. Jakubowski et al. profile →
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.

1982 486 citations Clifford Pukel, Kenneth O. Lloyd et al. The Journal of Experimental Medicine profile →
Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer

1978 397 citations Carl Pinsky, Herbert F. Oettgen et al. profile →
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

1976 376 citations Herbert F. Oettgen, Lloyd J. Old et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herbert F. Oettgen United States	64	6.0k	5.0k	4.6k	3.7k	2.1k	221	14.6k
Ingegerd Hellström United States	72	8.5k 1.4×	5.6k 1.1×	5.3k 1.2×	4.6k 1.3×	1.1k 0.5×	293	18.0k
Ian F. C. McKenzie Australia	64	8.0k 1.3×	6.0k 1.2×	1.8k 0.4×	4.3k 1.2×	3.0k 1.4×	459	15.6k
Chikao Morimoto United States	74	8.4k 1.4×	5.1k 1.0×	5.6k 1.2×	2.2k 0.6×	703 0.3×	339	18.5k
Evan M. Hersh United States	49	3.9k 0.6×	3.9k 0.8×	4.3k 0.9×	1.6k 0.4×	557 0.3×	253	11.5k
Walter Newman United States	51	9.0k 1.5×	3.1k 0.6×	2.6k 0.6×	1.7k 0.5×	905 0.4×	108	16.3k
Steven J. Burakoff United States	71	9.7k 1.6×	7.7k 1.5×	3.5k 0.8×	2.4k 0.6×	785 0.4×	278	17.3k
Harvey Cantor United States	77	13.5k 2.2×	4.8k 1.0×	2.8k 0.6×	2.5k 0.7×	712 0.3×	252	20.2k
Hiroshi Shiku Japan	64	6.6k 1.1×	6.7k 1.3×	4.4k 1.0×	1.4k 0.4×	1.1k 0.5×	535	16.3k
Eva Klein Sweden	53	7.6k 1.3×	3.1k 0.6×	4.6k 1.0×	1.6k 0.4×	478 0.2×	310	13.0k
Albert F. LoBuglio United States	54	3.0k 0.5×	3.6k 0.7×	2.9k 0.6×	2.6k 0.7×	571 0.3×	189	9.5k

Countries citing papers authored by Herbert F. Oettgen

Since Specialization

Citations

This map shows the geographic impact of Herbert F. Oettgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert F. Oettgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert F. Oettgen more than expected).

Fields of papers citing papers by Herbert F. Oettgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert F. Oettgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert F. Oettgen. The network helps show where Herbert F. Oettgen may publish in the future.

Co-authorship network of co-authors of Herbert F. Oettgen

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert F. Oettgen. A scholar is included among the top collaborators of Herbert F. Oettgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert F. Oettgen. Herbert F. Oettgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herr, Harry W., David M. Schwalb, Zuo‐Feng Zhang, et al.. (1995). Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.. Journal of Clinical Oncology. 13(6). 1404–1408. 241 indexed citations

Yin, Beatrice W.T., George Y. Wong, Kenneth O. Lloyd, Herbert F. Oettgen, & Sydney Welt. (1991). Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases. Journal of Immunological Methods. 144(2). 165–173. 1 indexed citations

Bander, Neil H., Connie L. Finstad, Carlos Cordon‐Cardo, et al.. (1989). Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas.. PubMed. 49(23). 6774–80. 46 indexed citations

Gabrilove, Janice, Ann A. Jakubowski, Katie Fain, et al.. (1988). Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.. Journal of Clinical Investigation. 82(4). 1454–1461. 183 indexed citations

Real, Francisco X., et al.. (1988). IFN- gamma -regulated expression of a differentiation antigen of human cells.. The Journal of Immunology. 140(5). 1571–1576. 6 indexed citations

Morishita, H., Hiroshi Shiku, Keizo Horibe, et al.. (1986). Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.. The Journal of Experimental Medicine. 163(2). 452–457. 10 indexed citations

Hawkins, Michael, Susan E. Krown, Ernest C. Borden, et al.. (1984). American cancer society Phase I trial of naturally produced beta-interferon.. PubMed. 44(12 Pt 1). 5934–8. 21 indexed citations

Houghton, Alan N., Timothy M. Thomson, Daniel Gross, Herbert F. Oettgen, & L J Old. (1984). Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.. The Journal of Experimental Medicine. 160(1). 255–269. 196 indexed citations

Palladino, Michael A., Yuichi Obata, Elisabeth Stockert, & Herbert F. Oettgen. (1983). Characterization of interleukin 2-dependent cytotoxic T-cell clones: specificity, cell surface phenotype, and susceptibility to blocking by Lyt antisera.. PubMed. 43(2). 572–6. 34 indexed citations

10.

Krown, Susan E., et al.. (1983). Phase I Trial with the Interferon Inducer Poly I:C/Poly-L-Lysine (Poly ICL). Journal of Interferon Research. 3(3). 281–290. 10 indexed citations

11.

Herr, Harry W., Carl Pinsky, Willet F. Whitmore, Herbert F. Oettgen, & Myron R. Melamed. (1983). Effect of intravesical bacillus calmette-guerin (BCG) on carcinomain situ of the bladder. Cancer. 51(7). 1323–1326. 102 indexed citations

12.

Pukel, Clifford, Kenneth O. Lloyd, Luiz R. Travassos, et al.. (1982). GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.. The Journal of Experimental Medicine. 155(4). 1133–1147. 486 indexed citations breakdown →

13.

Mertelsmann, Roland, Toby Gee, Sanford Kempin, et al.. (1981). Treatment of acute nonlymphocytic leukemia in adults: Response to 2,2-anhydro-1-B-D-Arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol. Cancer. 48(10). 2136–2142. 10 indexed citations

14.

Shiku, Hiroshi, et al.. (1977). Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.. The Journal of Experimental Medicine. 145(3). 784–789. 91 indexed citations

15.

Shiku, Hiroshi, Takashi Takahashi, & Herbert F. Oettgen. (1976). Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.. The Journal of Experimental Medicine. 144(4). 873–881. 185 indexed citations

16.

Oettgen, Herbert F.. (1973). Immunbiologie des krebses. European Archives of Oto-Rhino-Laryngology. 205(1). 21–36. 1 indexed citations

17.

Bloom, Barry R., et al.. (1971). ON THE NUMBER AND NATURE OF ANTIGEN-SENSITIVE LYMPHOCYTES IN THE BLOOD OF DELAYED-HYPERSENSITIVE HUMAN DONORS. The Journal of Experimental Medicine. 133(4). 740–751. 39 indexed citations

18.

Oettgen, Herbert F.. (1969). L-Asparaginase: Ein neues Prinzip in der Chemotherapie maligner Neoplasien. Annals of Hematology. 19(6). 351–356. 1 indexed citations

19.

Pribilla, W & Herbert F. Oettgen. (1968). Isotopenuntersuchungen bei Osteomyelofibrose. Annals of Hematology. 18(3). 178–182. 3 indexed citations

20.

Harries, James, et al.. (1963). Haemodynamic Effects of Occlusion of Abdominal Aorta During Nitorgen Mustard Therapy. BMJ. 2(5360). 783–786. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact